We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current TKNO market cap is 51.85M. The company's latest EPS is USD -0.9010 and P/E is -1.37.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Revenue | 9.12M | 11.53M | 8.17M | 7.87M | 9.29M |
| Operating Income | -8.95M | -7M | -6.57M | -13.05M | -7.99M |
| Net Income | -8.82M | -7.15M | -10.15M | -10.66M | -8.1M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 31.3M | 36.89M | 41.42M | 36.68M |
| Operating Income | 4.66M | -12.01M | -49.66M | -35.56M |
| Net Income | 3.57M | -9.8M | -47.47M | -36.78M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Assets | 141.02M | 132.55M | 138.39M | 128.59M | 120.82M |
| Total Liabilities | 48.93M | 46.34M | 38.73M | 38.55M | 37.44M |
| Total Equity | 92.09M | 86.21M | 99.65M | 90.04M | 83.38M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 62.91M | 166.51M | 152.26M | 128.59M |
| Total Liabilities | 10.51M | 23.31M | 52.38M | 38.55M |
| Total Equity | 52.41M | 143.2M | 99.89M | 90.04M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Operating | -7.68M | -11.54M | -15.92M | -18.81M | -6.56M |
| Investing | -4.31M | -6.65M | -7.62M | -7.74M | 13k |
| Financing | -25k | -205k | 13.42M | 12.8M | -343k |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 2.51M | -9.07M | -27.4M | -18.81M |
| Investing | -1.74M | -17.52M | -28.15M | -7.74M |
| Financing | -1.6M | 110.79M | 10.27M | 12.8M |
| Market Cap | 51.85M |
| Price to Earnings Ratio | -1.37 |
| Price to Sales Ratio | 1.37 |
| Price to Cash Ratio | 1.76 |
| Price to Book Ratio | 0.56 |
| Dividend Yield | - |
| Shares Outstanding | 40.82M |
| Average Volume (1 week) | 17.79k |
| Average Volume (1 Month) | 58.21k |
| 52 Week Change | -52.61% |
| 52 Week High | 4.27 |
| 52 Week Low | 1.155 |
| Spread (Intraday) | 0.28 (19.18%) |
| Company Name | Alpha Teknova Inc |
| Address |
108 w. 13th street suite 100 wilmington, delaware 19801 |
| Website | https://www.teknova.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
